Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study

Authors: Riess, Jonathan W., Lara, Matthew S., Lopez de Rodas, Miguel, Luxardi, Guillaume, Herbert, Samantha, Shimoda, Michiko, Kelly, Karen, Meerlev, Alexander, Moore, Elizabeth, Beckett, Laurel, Monjazeb, Arta, Schalper, Kurt, Maverakis, Emanual, Gandara, David R.

Source: In JTO Clinical and Research Reports October 2024 5(10)